Shelton Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.8M Sell
255,813
-23,873
-9% -$2.76M 0.67% 25
2025
Q4
$29.4M Buy
279,686
+91,910
+49% +$8.63M 0.58% 35
2025
Q3
$15.8M Buy
187,776
+9,724
+5% +$801K 0.34% 68
2025
Q2
$14.1M Buy
178,052
+22,024
+14% +$1.75M 0.32% 78
2025
Q1
$14M Buy
156,028
+21,557
+16% +$2.01M 0.33% 73
2024
Q4
$13.4M Sell
134,471
-9,267
-6% -$955K 0.33% 70
2024
Q3
$16.3M Buy
143,738
+28,030
+24% +$3.33M 0.42% 47
2024
Q2
$14.3M Buy
115,708
+19,686
+21% +$2.54M 0.39% 52
2024
Q1
$12.7M Sell
96,022
-39,708
-29% -$4.89M 0.36% 63
2023
Q4
$14.8M Buy
135,730
+30,038
+28% +$3.12M 0.47% 47
2023
Q3
$10.9M Buy
105,692
+24,200
+30% +$2.61M 0.4% 50
2023
Q2
$9.4M Buy
81,492
+34,281
+73% +$3.89M 0.34% 59
2023
Q1
$5.02M Buy
47,211
+36,211
+329% +$3.91M 0.21% 110
2022
Q4
$1.22M Sell
11,000
-180,815
-94% -$18.5M 0.13% 191
2022
Q3
$16.5M Buy
191,815
+15,704
+9% +$1.4M 0.79% 20
2022
Q2
$16.1M Sell
176,111
-32,296
-15% -$2.86M 0.72% 23
2022
Q1
$17.1M Buy
208,407
+37,189
+22% +$2.93M 0.63% 24
2021
Q4
$13.1M Buy
171,218
+82,244
+92% +$6.55M 0.46% 41
2021
Q3
$6.68M Sell
88,974
-6,079
-6% -$462K 0.26% 90
2021
Q2
$7.39M Sell
95,053
-23,635
-20% -$1.76M 0.28% 81
2021
Q1
$8.73M Buy
118,688
+6,430
+6% +$474K 0.3% 70
2020
Q4
$8.76M Buy
112,258
+31,336
+39% +$2.4M 0.39% 53
2020
Q3
$6.41M Buy
80,922
+13,805
+21% +$1.08M 0.27% 81
2020
Q2
$4.95M Buy
67,117
+30,706
+84% +$2.31M 0.27% 75
2020
Q1
$2.67M Sell
36,411
-20,642
-36% -$1.62M 0.19% 109
2019
Q4
$4.95M Sell
57,053
-4,990
-8% -$410K 0.27% 74
2019
Q3
$4.98M Sell
62,043
-86
-0.1% -$6.89K 0.29% 69
2019
Q2
$4.97M Buy
62,129
+56,877
+1,083% +$4.36M 0.29% 67
2019
Q1
$60.2K Sell
5,252
-31,059
-86% -$2.32M 0.24% 92
2018
Q4
$2.65M Sell
36,311
-315
-0.9% -$22.2K 0.18% 116
2018
Q3
$2.48M Sell
36,626
-11,774
-24% -$750K 0.14% 142
2018
Q2
$2.8M Sell
48,400
-6,775
-12% -$382K 0.17% 126
2018
Q1
$2.87M Sell
55,175
-170
-0.3% -$9.18K 0.19% 113
2017
Q4
$2.97M Hold
55,345
0.19% 116
2017
Q3
$3.38M Hold
55,345
0.23% 103
2017
Q2
$3.38M Sell
55,345
-841
-1% -$51.2K 0.24% 98
2017
Q1
$3.41M Sell
56,186
-9,223
-14% -$560K 0.24% 85
2016
Q4
$3.67M Buy
65,409
+796
+1% +$46.6K 0.28% 68
2016
Q3
$3.85M Sell
64,613
-6,104
-9% -$357K 0.32% 58
2016
Q2
$3.89M Buy
70,717
+8,867
+14% +$472K 0.34% 59
2016
Q1
$3.12M Sell
61,850
-4,611
-7% -$226K 0.28% 75
2015
Q4
$3.35M Buy
66,461
+638
+1% +$32.2K 0.32% 65
2015
Q3
$3.1M Buy
65,823
+1,363
+2% +$72.4K 0.34% 58
2015
Q2
$3.5M Buy
64,460
+5,221
+9% +$293K 0.36% 55
2015
Q1
$3.25M Buy
59,239
+2,829
+5% +$160K 0.35% 59
2014
Q4
$3.06M Buy
56,410
+640
+1% +$35.7K 0.36% 60
2014
Q3
$3.15M Sell
55,770
-1,887
-3% -$106K 0.42% 47
2014
Q2
$3.18M Sell
57,657
-5,914
-9% -$323K 0.44% 44
2014
Q1
$3.44M Buy
63,571
+4,088
+7% +$212K 0.5% 37
2013
Q4
$2.84M Hold
59,483
0.43% 51
2013
Q3
$2.7M Hold
59,483
0.45% 44
2013
Q2
$2.64M Buy
+59,483
New +$2.66M 0.48% 41

Other funds holding MRK

Shelton Capital Management's MRK Position: Q1 2026 in Review

Shelton Capital Management reduced its Merck (MRK) stake by 8.5% in Q1 2026, selling an estimated $2.76M and leaving 255,813 shares worth $30.8M. The position accounts for 0.67% of the portfolio, ranked #25.

Shelton Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Shelton Capital Management held 255,813 shares of Merck worth $30.8M as of Q1 2026.
  • Shelton Capital Management sold 23,873 Merck shares in Q1 2026, an estimated $2.76M.
  • Merck made up 0.67% of Shelton Capital Management's portfolio in Q1 2026, its #25 holding.
  • Shelton Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.